Management of Chronic Heart Failure: Biomarkers, Monitors, and Disease Management Programs
Background: The management of patients with heart failure has been evolving given the complex nature of the disease and the increasing number of patients. Findings: Biomarkers, and in particular the natriuretic peptides, have been studied to assist with diagnosis, chronic management, and prognosis i...
Guardado en:
Autores principales: | Parul U. Gandhi, Sean Pinney |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Ubiquity Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2bffb01905454d919142cfc528640ae1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Universal Definition and Classification of Heart Failure Triggers the Standardization of Diagnosis and Treatment of Heart Failure
por: XU Fen, et al.
Publicado: (2021) -
Differential effects of doxorubicin on atrial natriuretic peptide expression in vivo and in vitro
por: RAHMAN,ASIM, et al.
Publicado: (2001) -
Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study
por: Michael C. Wang, et al.
Publicado: (2021) -
The role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2011) -
Cardiac biomarkers in dogs with visceral leishmaniasis
por: Silva,VBC, et al.
Publicado: (2016)